TPC:NYSETutor Perini Corporation Analysis
Data as of 2026-06-12 - not real-time
$73.61
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Tutor Perini (TPC) is trading at $73.61, just below its 20‑day SMA of $74.05 but above the 200‑day SMA of $72.36, indicating a short‑term pull‑back within a longer‑term uptrend. The RSI sits at 45.7, suggesting neutral momentum, while the MACD histogram turned slightly positive (0.027) and the MACD line marginally crossed above its signal, delivering a modest bullish signal. Volatility is elevated at roughly 70% over the past 30 days and beta exceeds 1.7, pointing to a stock that moves sharply with market swings. Fundamentals show a trailing P/E of 50.4 versus an industry average of 30.4, and a DCF‑derived fair value of $273, highlighting a substantial valuation gap. However, the company posted 11.5% revenue growth, a forward EPS of $6.02 (up from $1.46 trailing), and a robust $19.8 B backlog, indicating strong growth prospects. Recent news notes a new $81.8 M contract and mixed earnings reactions, with some analysts upgrading on backlog quality while others caution on margin pressure.
The dividend yield is modest at 0.33% with an 8% payout ratio, suggesting sustainability, and the balance sheet is solid with a debt‑to‑equity of 36.8%. Given the high valuation, elevated volatility, and cyclical industry exposure, the stock presents a nuanced risk‑reward profile: upside potential if growth materializes but downside risk from overvaluation and market sensitivity.
The dividend yield is modest at 0.33% with an 8% payout ratio, suggesting sustainability, and the balance sheet is solid with a debt‑to‑equity of 36.8%. Given the high valuation, elevated volatility, and cyclical industry exposure, the stock presents a nuanced risk‑reward profile: upside potential if growth materializes but downside risk from overvaluation and market sensitivity.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price near immediate support at $68.61
- Neutral technical indicators (RSI, MACD)
- Recent earnings disappointment
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Strong $19.8 B backlog and new $81.8 M contract
- Forward EPS growth and lower forward P/E (~12x)
- Persistently high valuation relative to peers
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustained revenue growth and expanding margin potential
- Low dividend payout supporting reinvestment
- DCF fair value indicating significant upside
Key Metrics & Analysis
Financial Health
Revenue Growth11.50%
Profit Margin1.37%
P/E Ratio50.4
ROE11.40%
ROA2.97%
Debt/Equity36.84
P/B Ratio3.2
Op. Cash Flow$872.1M
Free Cash Flow$665.9M
Industry P/E30.4
Technical Analysis
TrendNeutral
RSI45.7
Support$68.61
Resistance$84.00
MA 20$74.05
MA 50$80.68
MA 200$72.36
MACDBullish
VolumeStable
Fear & Greed Index86.91
Valuation
Fair Value$273.20
Target Price$113.25
Upside/Downside53.85%
GradeOvervalued
TypeGrowth
Dividend Yield0.33%
Risk Assessment
Beta1.71
Volatility69.63%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.